MUSTANG BIO, INC. (MBIO)
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.
Address
377 PLANTATION STREET
WORCESTER, MA 01605
Founded
2015
Number of Employees
113
Website
http://www.mustangbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)